Working… Menu

PTK787 in Refractory or Relapsed Diffuse Large Cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00511043
Recruitment Status : Terminated (Manufacturer stopped drug development)
First Posted : August 3, 2007
Last Update Posted : December 9, 2014
Novartis Pharmaceuticals
Information provided by (Responsible Party):
David Rizzieri, MD, Duke University

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 2009
Actual Study Completion Date : June 2010
Certification/Extension First Submitted : September 7, 2012